Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
ALISO VIEJO, Calif., Sept. 20, 2016 -- NVISION Eye Centers—a national leader in providing the finest suite of ophthalmology services for patients including: custom and Topo-guided LASIK, KAMRA Inlay, cataract surgery and other vision correction procedures— is pleased to introduce the Symfony Lens to its product offerings. NVISION Eye Centers offers an array of lifestyle lenses for cataract patients and has started placing the FDA-approved lens for its patients in California, Arizona, Oregon, and Nevada.
"The Symfony lens is an advancement in lens technology that provides cataract patients with crisp and clear near, intermediate and distance vision, even if the patient has an astigmatism,” says NVISION Eye Centers' medical director, Dr. Jeff Machat, who oversees and trains the company’s team of surgeons on new technologies including best practices, techniques, and pre- and post observations. "NVISION’s Crystal Clear Vision center in Toronto, Canada has been successfully placing the Symfony lens for its Canadian patients for several years, and we are thrilled to be able to now offer such a well-studied, finely-tuned device to our patients in the United States."
The Symfony lens is the only intraocular lens in the United States that provides a full range of continuous vision following cataract surgery, while also mitigating the effects of presbyopia, or near vision loss. Patients needing to rid themselves of the cloudiness, caused by cataracts, can also eliminate the need for distance or reading glasses in one procedure with the revolutionary Symfony Lens or its counterpart—the Symfony Toric —for cataract patients with astigmatism.
For more information, or to schedule a consultation, call (877) 455-9942 or visit: https://nvisioncenters.com/procedures/laser-cataract-surgery.
ABOUT NVISION EYE CENTERS: NVISION Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Nevada, Oregon, Arizona and Toronto, Canada. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 100,000 procedures throughout his esteemed career. With more than 1,900 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call (877) 455-9942.
